Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Efficacy and Safety of the CG-100 Intraluminal Bypass Device

NCT: NCT04184973 · RECRUITING

NCT IDNCT04184973
StatusRECRUITING
Start Date2020-06-23
Completion2026-12-31
SponsorColospan Ltd. (INDUSTRY)
First posted
Last updated

Brief Summary

A randomized trial to assess the safety and efficacy of CG-100 for reducing stoma creation rate in subjects undergoing mesorectal excision.

Frequently Asked Questions

What is Efficacy and Safety of the CG-100 Intraluminal Bypass Device?

Efficacy and Safety of the CG-100 Intraluminal Bypass Device is a clinical trial registered under NCT04184973. Current status: RECRUITING.

What is the status of NCT04184973?

The current status of NCT04184973 (Efficacy and Safety of the CG-100 Intraluminal Bypass Device) is: RECRUITING.

When did Efficacy and Safety of the CG-100 Intraluminal Bypass Device start?

Efficacy and Safety of the CG-100 Intraluminal Bypass Device started on 2020-06-23.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑